Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

HISTORICAL FACTS: Effector rapeutics - The Untold Story

12 Health Care Stocks Moving In Friday's Intraday Session

Benzinga · Sep 2, 2022

Stocks That Hit 52-Week Lows On Monday

Stocks That Hit 52-Week Lows On Monday

On Monday, 100 companies reached new 52-week lows.

Benzinga · Jul 25, 2022

4 Stocks Under $2 Insiders Are Aggressively Buying: NEXGEL, eFFECTOR Therapeutics And More

4 Stocks Under $2 Insiders Are Aggressively Buying: NEXGEL, eFFECTOR Therapeutics And More

U.S. crude oil futures traded higher by over 1% on Tuesday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall…

Benzinga · Jun 28, 2022

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

5 Value Stocks To Watch In The Healthcare Sector

What are Value Stocks?

Benzinga · Apr 18, 2022

eFFECTOR Therapeutics's Return On Capital Employed Overview

According to Benzinga Pro, during Q4, eFFECTOR Therapeutics (NASDAQ:EFTR) earned $19.05 million, a 114.54% increase from the preceding quarter. eFFECTOR Therapeutics's sales decreased to $311.00 thousand, a 27.17% change since Q3.

Benzinga · Mar 17, 2022

1

Coverage From

Benzinga

Organisations

Walgreens Boots Alliance

Quest Diagnostics

TRACON Pharmaceuticals

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Topics

inkl

Read news from The Economist, FT, and more,
with one subscription

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play